Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Take-at-home brain cancer treatment for children will soon be available on NHS
The combination treatment, which is given at home rather than in hospital, works by targeting the proteins made by the altered BRAF gene that is responsible for uncontrollable tumour growth.
Children with brain tumours will soon have access to drugs they can take at home, the NHS has announced.
The treatment is a first of its kind and clinical trials have shown it to significantly slow the progression of the disease, allowing children a better quality of life for longer.
The treatment is for children and young people with low-grade gliomas that have a specific genetic mutation.
https://news.sky.com/story/take-at-home-brain-cancer-treatment-for-children-will-soon-be-available-on-nhs-13121594
.
Finra: Insightful Podcast on the new T+1 change
#dcvax $nwbo #gbm
— Peter Davis (@peter_brit) April 17, 2024
Finra: Insightful Podcast on the new T + 1 changes (with full transcription) coming in May:
PODCAST
Preparing for Change: What to Know About the Shift to T+1
APRIL 16, 2024
On May 28th, U.S. markets are moving to a one-day settlement cycle, familiarly known… pic.twitter.com/6DAMnjrIwE
Marketing authorisations granted 15 to 31 March 2024
https://www.gov.uk/government/publications/marketing-authorisations-granted-in-2024
.
New science park planning consent in South Cambridge
Thanks abeta, more great questions
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) April 9, 2024
While the fud crowd continues down the rabbit hole of infinite bullshit, all of their manipulative narratives are being sunk on a daily basis, by - what was once known as .... logic, reason and facts.
Have you shown the fud crowd your finger today? https://t.co/eFfgUZJJtr
Is Investor Village really down for maintenance?
Or are they in fear of Cohen Milstein coming for them
https://www.investorvillage.com/
.
Another great post Chiugray, thanks 💥
UPDATE: Marketing authorisations granted 1 to 14 March 2024
We're not mentioned which was expected.
https://assets.publishing.service.gov.uk/media/66019d10f1d3a06c5532adb1/Marketing_authorisations_granted_1_March_to_14_March_2024.pdf
Whats age got to do with it.
Warren Buffett is 93
.
KEYTRUDA did not YET AGAIN meet its dual primary endpoints of overall survival (OS) and progression-free survival (PFS)
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) March 21, 2024
KEYTRUDA did not YET AGAIN meet its dual primary endpoints of overall survival (OS) and progression-free survival (PFS). Just saying.
Hint: DCVax-L is needed in combos. https://t.co/qoeHMv1uMo pic.twitter.com/AA0nJvmVfi
WOW, massive jump in Short Borrow Availability
An increase from 1.1 million to 10m million
Looks like someone is covering big time
https://www.shortablestocks.com/?NWBO
.
Interesting study reveals key mechanism of PD-1 function
Insights into the workings of an immune cell surface receptor, called PD-1, reveal how treatments that restrict its action can potentially be strengthened to improve their anticancer effect, a new study shows.
https://www.news-medical.net/news/20240309/Study-reveals-key-mechanism-of-PD-1-function.aspx
.
Early trial results from six patients with recurrent glioblastoma may be a promising step towards developing cell therapies for solid tumors
https://www.pennmedicine.org/news/news-releases/2024/march/dual-target-cell-therapy-appears-to-shrink-brain-tumors
Targeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise as a strategy for reducing solid tumor growth in patients with recurrent glioblastoma
Others still seem to think that targeting two proteins is enough
Thats why DCVax is superior, targeting the full spectrum of antigens on the tumor
.
Never seen any arm of any trial show mOS over five years in GBM. UCLA is trailblazing on treatment of this disease and the media is just crickets.
Doc, I have to repeat this again because I feel this is one of the most exciting parts. For this combo trial as shown in the figure, tumor-associated macrophage (green dots) is the culprit in suppressing ant-tumor immune response and Plx3397 as shown in other publications can… pic.twitter.com/Uszv7Exrzs
— d_stock (@d_stock07734) March 18, 2024
Nineteen days after the $NWBO submission to the MHRA, the FDA without much fanfare announced an initiative that built on top of ORBIS called Cogent Global
https://twitter.com/BIO99_BIO99/status/1769357382516351242
.
How nice is this - Laura Nuttall Way
This means the absolute world to us.
— shitscaredmum (@shitscaredmum) March 16, 2024
Laura’s name on a little road behind the beautiful village park where we spent so much time together.
Thank you @Andrew4Pendle Pendle Council & whoever secretly renamed the road on Google maps last year, she would have loved this#BeMoreLaura pic.twitter.com/SgOHZHoLrk
Smokey, wishing you all the best 👍️
.
This is definately NOT Nigel French
He's a kind and quite soft spoken individual
As usual, your wrong
I can't stand this 'Neurosis' guy, he comes across as a right arsehole.
Get your facts right
.
Marketing authorisations granted 15 February 2024 to 29 February 2024
https://assets.publishing.service.gov.uk/media/65e9930362ff48001a87b312/Marketing_authorisations_granted_15_February_to_29_February_2024.pdf
Not long before we're on the list
.
Breakthrough research on glioma progression wins BIAL Award in Biomedicine
https://www.news-medical.net/news/20240221/Breakthrough-research-on-glioma-progression-wins-BIAL-Award-in-Biomedicine.aspx
.
Marketing authorisations granted 1 to 14 February 2024
Latest authorisations granted:
https://assets.publishing.service.gov.uk/media/65d60fdf2ab2b3001a759664/Marketing_authorisations_granted_1_February_to_14_February_2024.pdf
Nothing yet on Northwest or DCVax / Mercidencel but won't be long before we're in this list 😀
.
The European Patent Convention (EPC) is a regional patent system,
allowing a single European patent application to cover 39 member states across Europe.
$NWBO
— 🇩🇰 The Danish Dude 🇩🇰 (@FlemmingBruce) February 19, 2024
The European Patent Convention (EPC) is a regional patent system, allowing a single European patent application to cover 39 member states across Europe.
EP3065772 - COMBINATIONS OF CHECKPOINT INHIBITORS AND THERAPEUTICS TO TREAT CANCER
Eat this fudders 🖕🏻 pic.twitter.com/8clvMLNhqE
Agree, J. Kelly Ganjei is highly respected
Anoher great post from Danish, the picture of LC is just pure gold.
https://stocktwits.com/TheDanishDude/message/561185073
.
Would be very interesting indeed.
Wonder if there is any way of finding out.
Perhaps PR's from the companies in question after they submitted?
.
If you think Alphapuppy is a fudster then you haven't been here long enough
Look at this message back in 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156299329
Why would he go to all this trouble back then
I think he is just frustrated, like we all are, as to why, after every piece of great news, the price goes nowhere.
We know exactly why that is.
Price manipulation by MM's to keep new investors away whilst they accumulate on the cheap.
.
Latest Marketing Authorisations for 2024
Great post mike00h and if you want most up to date Marketing Authorisations click here
.
WOW, big shout out to BIO9999 for this post .... 9 MONTHS AGO
Flaskworks’ is a Game Changer for Dendritic Cell Production
https://www.reddit.com/r/NWBO/comments/138158c/nwbo_flaskworks_is_a_game_changer_for_dendritic/
.
Great find starric, very interesting.
Cohen Milstein know what they're about.
.
#dcvax #allsolidtumors $nwbo #gbm
— Peter Davis (@peter_brit) February 2, 2024
Important to note:
Not only does Linda Liau present on both Friday and Saturday at the Texas Association of Neurological Surgeons (TANS) but is also listed as a KEYNOTE speaker at this event. Obviously Linda has something important to… pic.twitter.com/OrAJn2ke9T
We've done it!
— Brain Tumour Research (@braintumourrsch) January 31, 2024
Thanks to everyone who has signed our petition, which made this happen. It has been an exciting day, which will hopefully bring much-needed change.
Thanks to, Sam Suriakumar, @shitscaredmum, @theblkgardener, and @theoburrell for joining us.#BrainTumourPetition pic.twitter.com/0fJyBR9tGv
Court Case Latest Update
🧑⚖️NWBO Lawsuit Update🧑⚖️
— hoffmann6383 (@hoffmann6383) January 31, 2024
In this post I'll provide a quick update on the recent flurry of filings in the $NWBO lawsuit.
The Case: Northwest Biotherapeutics, Inc v. Canaccord Genuity LLC, 1:22-cv-10185, (S.D.N.Y.)
The Docket: https://t.co/SNKTxns1sw
On January 26th $NWBO filed… pic.twitter.com/RNJ2FWVbmX
Successful National Glioblastoma Clinical Trial
Breakthrough blood test can spot lethal brain tumours
A simple blood test could help diagnose patients with the deadliest form of brain cancer, researchers have found.
Trials by the Brain Tumour Research Centre of Excellence, part of Imperial College London, found they could identify traces of the disease in standard blood samples.
Experts say it could speed up diagnosis and treatment, while reducing the need for invasive and risky surgery used to diagnose most brain tumours. They said the 'liquid biopsy' would be particularly beneficial for patients with inaccessible brain tumours, meaning they could start treatment as soon as possible.
https://www.dailymail.co.uk/health/article-13007943/blood-test-spot-lethal-brain-tumours.html
.
ATL, that's awesome due diligence
Many thanks
.